Abstract
The development of new bioactive glasses (BGs) with enhanced bioactivity and improved resistance to crystallization is crucial for overcoming the main challenges faced by commercial BGs. Most shaping processes require thermal treatments, which can induce partial crystallization, negatively impacting the biological and mechanical properties of the final product. In this study, we present a novel bioactive glass composition, S53P4_MSK, produced by a melt-quench route. This novel composition includes magnesium and strontium, known for their therapeutic effects, and potassium, recognized for improving the thermal properties of bioactive glasses. The thermal properties were investigated through differential thermal analysis, heating microscopy and sintering tests from 600 °C to 900 °C. These characterizations, combined with X-ray diffraction analysis, demonstrated the high sinterability without crystallization of S53P4_MSK, effectively mitigating related issues. The mechanical properties-elastic modulus, hardness and fracture toughness-were evaluated on the sintered sample by micro-indentation, showing high elastic modulus and hardness. The bioactivity of the novel BG was assessed following Kokubo's protocol and confirmed by scanning electron microscopy, X-ray energy dispersive spectroscopy, and Raman spectroscopy. The novel bioactive glass composition has shown high sinterability without crystallization at 700 °C, along with good mechanical properties and bioactivity.